Proposals

Proposals and Views on a possible Biomedical R&D Treaty

1999

MSF calls for an a medical R&D treaty to address research for neglected diseases, on the day it wins the Noble Prize.
Amsterdam Statement To Wto Member States On Access To Medicine, developed at the Increasing Access to Essential Drugs in a Globalised Economy Working Towards Solutions conference, organized by Health Action International, Médecins Sans Frontières, and Consumer Project on Technology, at Amsterdam, the Netherlands, November 25-26, 1999.

2001

2001 October 12 discussion on Intellectual Property, innovation and international trade agreements at the Wizards of OS, Berlin, Germany.
Jean-Marie Kindermans and Francine Matthys, Introductory note: The access to Essential Medicines Campaign, Tropical Medicine and International Health, Volume 6 NO 11 PP 955-956, November 2001.

2002

Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, et al. (2002) Drug development for neglected diseases: A deficient market and a public-health policy failure. Lancet 359: 2188–2194.

2003

James Love, From TRIPS to RIPS: A better Trade Framework to support Innovation in Medical Technologies, Agence nationale de recherches sur le sida/Institute d’ économie publique, Workshop on Economic issues related to access to HIV/AIDS care in developing countries, 27 May 2003.

2004

Torreele E, Usdin M, Chirac P. A needs-based pharmaceutical R&D agenda for neglected diseases. World Health Organization. 12 p. 31 July 2004.
James Love and Tim Hubbard in Bridges. Make Drugs Affordable: Replace TRIPs-plus by R&D-plus, June 2004.
James Love and Tim Hubbard. “A New Trade Framework for Global Healthcare R&D”. PLOS Biology. 2(2): e52 DOI: 10.1371/journal.pbio.0020052

2005

Kenya’s proposal to the WHO Executive Board for a “Global Framework on Essential Health R&D, 16 November 2005. This also contains a background documented submitted to the WHO Executive Board in January 2006.
Submission of Dr Tim Hubbard, Head of Human Genome Analysis, Sanger Institute, Reply to the comments requested by CIPIH and WHO to a proposal for a Medical Research and Development Treaty, 22 August 2005.
Priya Shetty for SciDev.net. More creative thinking needed on drug R&D, 3 May, 2005.
Call for global R&D health treaty resonates loudly. European Commission Research Headlines, 25 March 2005.
Eva Tallaksen for SciDev.net. World ‘needs global R&D health treaty’, 1 March, 2005.
Andrew Jack, WHO members urged to sign Kyoto-style medical treaty, Financial Times, 25 February 2005.
Request from 162 scientists, public health experts, law professors, economists, Nobel laureates, government officials, members of parliament, NGOs and others asking the WHO Executive Board and the CIPIH to evaluate a proposal for new global medical R&D treaty, 24 February 2005.
Medical Research and Development Treaty (MRDT), Discussion draft 4, 7 February 2005.
Dentico N, Ford N (2005) The Courage to Change the Rules: A Proposal for an Essential Health R&D Treaty. PLoS Med 2(2): e14. doi:10.1371/journal.pmed.0020014

2006

James Love, Measures to Enhance Access to Medical Technologies, and New Methods of Stimulating Medical R&D, UC Davis L. Rev., 2006.
Michelle Childs. IGWG Statement by Consumers International, 7 December 2006.
Thiru Balasubramaniam, WHO Eastern Mediterranean countries want discussion of patent pools and new R&D incentives, ip-health, 6 December 2006
Thiru Balasubramaniam, 10 Asian countries support global treaty on R&D, FromGeneva, 5 December 2006.
Thomas Faunce, “Toward a Multilateral Treaty on Safety and Cost-effectiveness of Medicines and Medical Devices,” WHO Public Hearing on Public Health, Innovation and Intellectual Property, 14 November 2006;
Colleen Daniels, Health Action International Europe, Submission to the World Health Organization, Public hearing on public health, innovation and intellectual property, November 2006.
James Love, Le Monde Diplomatique, Prizes rather than prices, May 2006.
James Love, Drug development incentives to improve access to essential medicines, Round Table Discussion, Bulletin of the World Health Organization, Volume 84, Number 5, May 2006, 408.
Ellen ’t Hoen, Report of the Commission on Intellectual Property Rights, Innovation and Public Health: a call to governments, Bulletin of the World Health Organization, Volume 84, Number 5, May 2006, 421-422.
David J Winters, Expanding global research and development for neglected diseases, Bulletin of the World Health Organization, Volume 84, Number 5, May 2006, 414-416.
Report of the Commission on Intellectual Property Rights, Innovation and Public Health. April 2006. Page 90.
Frances Williams, WHO to decide on medical R&D, 30 January 30 2006.
CPTech Statement on WHO EB Resolution on Global Framework for Essential Health R&D, 27 January 2006.
Kanaga Raja, Public support for Kenya-Brazil move at WHO on health R&D, SUNS, 26 January 2010.
Reuters, Scientists ask WHO to boost ‘neglected’ disease R&D, 25 Jan 2006.
Tove Iren S. Gerhardsen,R&D Resolution Formally Submitted To WHO Board Meeting, Intellectual Property Watch, , 24 January 2006.

2007

James Love, KEI comments to IGWG 2, 8 November 2007.
Michel Lotrowska, MSF comments to IGWG 2, 8 November 2007.
Mogha Kamal Smith, Oxfam comments to IGWG 2. 8 November 2007.
Sub-regional Meeting Consensus Document, Rio de Janeiro, Brazil, 3-5 September 2007.
Thiru Balasubramaniam. 60th WHA. Statement by Christian Medical Commission (CMC) Churches Action for Health and other organizations including Knowledge Ecology International (KEI), Health Action International and the Medecins sans Frontieres Access to Essential Medicines Campaign, 21 May 2007.
Carl Nathan, “Aligning pharmaceutical innovation with medical need,” Nature, Vol 13, No. 3, March 2007.
Manish Ashiya and Anu Jindal, Medical Research and Development Treaty: A New R&D Framework, Icfai Journal of Systems Management, Vol. 5, No. 1, pp. 23-31, February 2007.

2008

The WHO global strategy and plan of action on public health, innovation and intellectual property (WHA resolution 61.21), 24 May 2008.
James Love , KEI statement to resumed IGWG II bis, 1 May 2008.
Eminent Academics: IGWG Delegates Should Explore New Mechanisms to Correct Current Deficiencies in Medicine System, 28 April 2008.
WIPO Report on the International Patent System, SCP/12/3, Page 36, 15 April 2008.

2009

Statement of Bolivia on behalf of Bangladesh, Barbados, Bolivia and Suriname, and Cuba, Ecuador, Nicaragua and Venezuela on the Removal of WHO as a Stakeholder from Element 2.3(c) in the Plan of Action on Public Health, Innovation and Intellectual Property, 62nd World Health Assembly, 22 May 2009.
James Love, The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty, 22 May 2009.
Submission of Third World Network, Global Framework for Research & Development, Second Web-based Public Hearingg, The Expert Working Group on R&D Financing, August/September 2009.
Malini Aisola, WHO gets what role, Indian Express, 22 May 2009.
Proposal by Bangladesh, Barbados, Bolivia and Suriname: Proposal for WHO Discussions on a Biomedical R&D Treaty, 5 April 2009.
Proposal of Brazil: Innovative Mechanism for R&D for developing countries, The Expert Working Group on R&D Financing, March/April 2009.
Submission by South Africa-New and Innovative sources of funding to stimulate R&D, The Expert Working Group on R&D Financing, March/April 2009.

2010

WHA 63.28 Establishment of a Consultative Expert Working Group on Research and Development: Financing and Coordination, 21 May 2010.

2011

Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third World Network (TWN), An Essential Health and Biomedical R&D Treaty, 22 June 2011. Joint submission to the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG).

2012